cilostazol has been researched along with Hematochezia in 5 studies
Hematochezia: The passage of bright red blood from the rectum. The blood may or may not be mixed with formed stool in the form of blood, blood clots, bloody stool or diarrhea.
Excerpt | Relevance | Reference |
---|---|---|
"Aspirin is widely used for secondary prevention after stroke." | 8.87 | Cilostazol versus aspirin for secondary prevention of vascular events after stroke of arterial origin. ( Husain, MR; Kamal, AK; Khealani, BA; Naqvi, I, 2011) |
"We compared the efficacy and safety of cilostazol and aspirin in 2,672 Japanese patients with non-cardioembolic ischemic stroke." | 8.86 | [Results of the Cilostazol Stroke Prevention Study II (CSPS II): a randomized controlled trial for the comparison of cilostazol and aspirin in stroke patients]. ( Uchiyama, S, 2010) |
" Patients with diagnosis codes for ischemic stroke without cardiac disease were included and divided into two groups, those receiving cilostazol and those receiving clopidogrel." | 8.31 | Long-term effectiveness and safety of cilostazol versus clopidogrel in secondary prevention of noncardioembolic ischemic stroke. ( Je, NK; Lee, YJ, 2023) |
"Aspirin is widely used for secondary prevention after stroke." | 4.87 | Cilostazol versus aspirin for secondary prevention of vascular events after stroke of arterial origin. ( Husain, MR; Kamal, AK; Khealani, BA; Naqvi, I, 2011) |
"We compared the efficacy and safety of cilostazol and aspirin in 2,672 Japanese patients with non-cardioembolic ischemic stroke." | 4.86 | [Results of the Cilostazol Stroke Prevention Study II (CSPS II): a randomized controlled trial for the comparison of cilostazol and aspirin in stroke patients]. ( Uchiyama, S, 2010) |
"Replacement of thienopyridine with aspirin or cilostazol may be acceptable for minimizing both the risk of post-ESD bleeding and thromboembolism in patients with EGC." | 4.31 | Association between perioperative management of antiplatelet agents and risk of post-endoscopic submucosal dissection bleeding in early gastric cancer: analysis of a nationwide multicenter study. ( Asahina, Y; Fujishiro, M; Hasatani, K; Hatta, W; Hayashi, Y; Hikichi, T; Hoteya, S; Iguchi, M; Inoue, T; Kikuchi, D; Kiyotoki, S; Kobayashi, M; Kuribayashi, S; Mabe, K; Masamune, A; Matsumura, T; Michida, T; Mikami, T; Miura, Y; Morita, Y; Nagami, Y; Nakamatsu, D; Narasaka, T; Nebiki, H; Nishikawa, J; Ohnita, K; Sugimoto, M; Sumiyoshi, T; Suzuki, H; Tomida, H; Tsuji, S; Tsuji, Y; Ueyama, H; Yabuuchi, Y; Yada, T; Yamaguchi, S; Yoshio, T, 2023) |
" Patients with diagnosis codes for ischemic stroke without cardiac disease were included and divided into two groups, those receiving cilostazol and those receiving clopidogrel." | 4.31 | Long-term effectiveness and safety of cilostazol versus clopidogrel in secondary prevention of noncardioembolic ischemic stroke. ( Je, NK; Lee, YJ, 2023) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 2 (40.00) | 24.3611 |
2020's | 2 (40.00) | 2.80 |
Authors | Studies |
---|---|
Miura, Y | 1 |
Tsuji, Y | 1 |
Yoshio, T | 1 |
Hatta, W | 1 |
Yabuuchi, Y | 1 |
Hoteya, S | 1 |
Kikuchi, D | 1 |
Tsuji, S | 1 |
Nagami, Y | 1 |
Hikichi, T | 1 |
Kobayashi, M | 1 |
Morita, Y | 1 |
Sumiyoshi, T | 1 |
Iguchi, M | 1 |
Tomida, H | 1 |
Inoue, T | 1 |
Mikami, T | 1 |
Hasatani, K | 1 |
Nishikawa, J | 1 |
Matsumura, T | 1 |
Nebiki, H | 1 |
Nakamatsu, D | 1 |
Ohnita, K | 1 |
Suzuki, H | 1 |
Ueyama, H | 1 |
Hayashi, Y | 1 |
Sugimoto, M | 1 |
Yamaguchi, S | 1 |
Michida, T | 1 |
Yada, T | 1 |
Asahina, Y | 1 |
Narasaka, T | 1 |
Kuribayashi, S | 1 |
Kiyotoki, S | 1 |
Mabe, K | 1 |
Masamune, A | 1 |
Fujishiro, M | 1 |
Lee, YJ | 1 |
Je, NK | 1 |
Yasuda, H | 1 |
Yamada, M | 1 |
Sawada, S | 1 |
Endo, Y | 1 |
Inoue, K | 1 |
Asano, F | 1 |
Takeyama, Y | 1 |
Yoshiba, M | 1 |
Kamal, AK | 1 |
Naqvi, I | 1 |
Husain, MR | 1 |
Khealani, BA | 1 |
Uchiyama, S | 1 |
2 reviews available for cilostazol and Hematochezia
Article | Year |
---|---|
Cilostazol versus aspirin for secondary prevention of vascular events after stroke of arterial origin.
Topics: Asian People; Aspirin; Brain Ischemia; Cause of Death; Cilostazol; Gastrointestinal Hemorrhage; Huma | 2011 |
[Results of the Cilostazol Stroke Prevention Study II (CSPS II): a randomized controlled trial for the comparison of cilostazol and aspirin in stroke patients].
Topics: Aspirin; Cilostazol; Gastrointestinal Hemorrhage; Humans; Japan; Platelet Aggregation Inhibitors; Ra | 2010 |
3 other studies available for cilostazol and Hematochezia
Article | Year |
---|---|
Association between perioperative management of antiplatelet agents and risk of post-endoscopic submucosal dissection bleeding in early gastric cancer: analysis of a nationwide multicenter study.
Topics: Aspirin; Cilostazol; Endoscopic Mucosal Resection; Gastric Mucosa; Gastrointestinal Hemorrhage; Gast | 2023 |
Long-term effectiveness and safety of cilostazol versus clopidogrel in secondary prevention of noncardioembolic ischemic stroke.
Topics: Aspirin; Cilostazol; Clopidogrel; Drug Therapy, Combination; Gastrointestinal Hemorrhage; Hemorrhagi | 2023 |
Upper gastrointestinal bleeding in patients receiving dual antiplatelet therapy after coronary stenting.
Topics: Adult; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Aspirin; Cilostazol; Clopidogrel; Co | 2009 |